Interestingly, decreased cell proliferation rate was observed in MCF-7/Dox transduced with UCP-2 shRNA compared to shScramble, which indicated that UCP-2 might mediate the Doxorubicin resistance in breast cancer cells. Here, UCP2 is linked to breast cancer.